Eribulin Mesylate Injection
Product Images NDC 43598-125

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 43598-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

This document contains information about a medication called Eribulin Mesylate Injection, including details such as storage temperature requirements, dosage, manufacturer information, and barcode specifications for tracking purposes. It is important to follow the provided instructions for proper use and storage of the medication.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Structure (Structure)

FDA Label Image

Viallabel (Viallabel)

This text is a product label for Eribulin Mesylate injection, a sterile solution indicated for intravenous use as a cytotoxic agent. It contains 1mg of Eribulin Mesylate per 2 mL, with dosing information and storage instructions provided. The product is manufactured by Dr. Reddy's Laboratories Inc. in India and distributed from Princeton, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.